Tower Research Capital (TRC)’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,037
Closed -$10.2K 6298
2023
Q3
$10.2K Buy
4,037
+2,302
+133% +$7.19K ﹤0.01% 4136
2023
Q2
$6.17K Buy
1,735
+657
+61% +$3.01K ﹤0.01% 4729
2023
Q1
$6K Buy
+1,078
New +$10K ﹤0.01% 4914
2022
Q4
Sell
-85
Closed -$1K 6600
2022
Q3
$1K Sell
85
-218
-72% -$3.4K ﹤0.01% 5912
2022
Q2
$6K Sell
303
-633
-68% -$23.2K ﹤0.01% 4995
2022
Q1
$104K Buy
936
+658
+237% +$82.2K ﹤0.01% 2175
2021
Q4
$46K Sell
278
-4
-1% -$693 ﹤0.01% 2830
2021
Q3
$51K Sell
282
-711
-72% -$145K ﹤0.01% 2953
2021
Q2
$188K Buy
993
+604
+155% +$103K ﹤0.01% 1979
2021
Q1
$75K Sell
389
-39
-9% -$9.05K ﹤0.01% 2808
2020
Q4
$92K Sell
428
-2,046
-83% -$456K ﹤0.01% 2430
2020
Q3
$574K Buy
2,474
+1,999
+421% +$576K 0.01% 1535
2020
Q2
$156K Buy
+475
New +$100K 0.01% 2027
2019
Q4
Sell
-557
Closed -$42K 4587
2019
Q3
$42K Buy
+557
New +$64.7K ﹤0.01% 1928

Other funds holding VAPO

Tower Research Capital (TRC)'s VAPO Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Vapotherm, Inc. Common Stock (VAPO) in Q4 2023, closing a stake of 4,037 shares — an estimated $10.2K sold.

Tower Research Capital (TRC) first reported a position in VAPO in Q3 2019 and held it in 14 quarters. The position peaked at $574K in Q3 2020. 3 funds tracked by Wall St. Rank hold VAPO as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Vapotherm, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,037 Vapotherm, Inc. Common Stock shares in Q4 2023, an estimated $10.2K.
  • Tower Research Capital (TRC) first reported a position in Vapotherm, Inc. Common Stock in Q3 2019 and held it in 14 quarters.
  • Tower Research Capital (TRC)'s Vapotherm, Inc. Common Stock position peaked at $574K in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.